Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06124833Recruiting

Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory Bowel Disease

Role: collaborator

NCT05770687Recruiting

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

Role: collaborator

NCT05820048Phase 4Unknown

The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)

Role: lead

NCT05770674Not ApplicableUnknown

Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES

Role: collaborator

NCT01239914Completed

CathOlic Medical Center percutAneous Coronary inTervention Registry (COACT)

Role: collaborator

NCT03778918Unknown

The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group

Role: collaborator

NCT02978989Not ApplicableUnknown

Solo and Non-solo Approach for Laparoscopic Cholecystectomy

Role: lead

All 7 trials loaded